<?xml version="1.0" encoding="UTF-8"?>
<ref id="B75-pharmaceuticals-13-00455">
 <label>75.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shalom-Sharabi</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Frenkel</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Caspi</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Bar-Sela</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Toledano</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Samuels</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Schiff</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Ben-Arye</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Integrative Oncology in Supportive Cancer Care in Israel</article-title>
  <source>Integr. Cancer Ther.</source>
  <year>2018</year>
  <volume>17</volume>
  <fpage>697</fpage>
  <lpage>706</lpage>
  <pub-id pub-id-type="doi">10.1177/1534735418764839</pub-id>
  <?supplied-pmid 29607685?>
  <pub-id pub-id-type="pmid">29607685</pub-id>
 </element-citation>
</ref>
